Nurse’s death linked to approved weight-loss drug
The death of a nurse from North Lanarkshire has been linked to the use of a weight-loss drug recently approved for use on the NHS. Susan McGowan, 58, took two low-dose injections of tirzepatide, known under the brand name Mounjaro, over the course of about two weeks before her death on 4 September.
Susan McGowan, 58, took just two injections before her death in September after the new generation of drugs were hailed as an ...
Mounjaro explained as Adam Lambert speaks out on Instagram live about his drastic weight loss and why he stopped taking ...
Susan McGowan took two doses of tirzepatide, sold under the brand name Mounjaro, before she died on 4 September ...
As the battle against obesity and diabetes heats up, two new superstars are entering the ring in Spain - Mounjaro (also known ...
The NHS rollout of appetite suppressing injections has been thrown into doubt after what is believed to be the first confirmed death linked to the controversial drugs ...
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
GLP-1 medications like Ozempic and Mounjaro can influence the volume of all-cause hospital admissions and bariatric surgeries, two studies suggest. Researchers at Boston-based Harvard Medical School ...
A weight drug recently legalised in the UK contributed to the death of a 58-year-old nurse, according to a new report.
The FDA became aware of the problem after a patient submitted a complaint to the regulator that a vial of semaglutide from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback